1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [18F] FLT PET predicts cellular proliferation in pediatric brain tumors
    Meeting Abstract

    Grant, F.; Sexton-Stallone, B.; Falone, A.; Brown, D.; Zurakowski, D.; Onar, A.; Dunkel, I.; Poussaint, T.; Fahey, F.; Treves, S. T.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Personalized dosimetry using (131)I-anti-CD45-apamistamab (Iomab-B) prior to high-dose myeloablative radioimmunotherapy for hematopoietic stem cell transplant (HCT) in active, relapsed, or refractory acute myelogenous leukemia: Novel re-induction and targeted conditioning feasibility and engraftment results from the SIERRA trial
    Meeting Abstract

    Griffeth, L.; Passalaqua, S.; Wiseman, G.; Avril, N.; Yap, W.; Chen, M. K.; Wagner, R.; Natwa, M.; Chasen, B.; Lamonica, D.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • F-18 FDG PET/CT for monitoring immunotherapy with PD-1 blockade in patients with advanced melanoma
    Meeting Abstract

    Ito, K.; Nakajima, R.; Michaud, L.; Weber, W.; Schoder, H.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Prognostic value of metabolic parameters on pretreatment F-18 FDG PET/CT in patients with advanced melanoma treated with pembrolizumab
    Meeting Abstract

    Ito, K.; Michaud, L.; Nakajima, R.; Weber, W.; Schoder, H.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • (89)Zr-immuno-PET: Towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo
    Meeting Abstract

    Jauw, Y.; O'Donoghue, J.; Zijlstra, J.; Hoekstra, O.; Menke-van der Houven van Oordt, C.; Morschhauser, F.; Carrasquillo, J.; Zweegman, S.; Pandit-Taskar, N.; Lammertsma, A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Initial experience with (18)F-flouroglutamine PET/CT imaging in brain tumor response assessment
    Meeting Abstract

    Goel, R.; Domfe, K.; Miller, A.; Krebs, S.; Young, R.; Grommes, C.; Tabar, V.; Dunphy, M.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Safety and effectiveness of (18)F-fluciclovine PET in adults with recurrent glioma: A retrospective observational study
    Meeting Abstract

    Bach-Gansmo, T.; Michaud, L.; Parent, E.; Akintayo, A.; Stevens, D.; Chau, A.; Dunphy, M.; Blasberg, R.; Schuster, D.; Goodman, M.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Increased biologically effective dose (BED) to the primary tumor improves survival in patients with oligometastatic NSCLC: A retrospective dose response analysis
    Meeting Abstract

    Farooqi, A.; Ludmir, E. B.; Mitchell, K. G.; Antonoff, M.; Gomez, D. R.; Gandhi, S.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • 18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following radical prostatectomy
    Meeting Abstract

    Eiber, M.; Kroenke, M.; Wurzer, A.; Ulbrich, L.; Jooay, L.; Maurer, T.; Kropf, S.; Horn, T.; Wester, H.; Weber, W.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Long-term disease control and survival observed after stereotactic body radiotherapy for oligometastatic breast cancer
    Meeting Abstract

    Wijetunga, N. A. A.; Dos Anjos, C. H.; Yang, T. J.; Gillespie, E. F.; Xu, A. J.; Yamada, Y.; Zhi, W.; Tsai, C. J.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save